« Return to News | Clinical Intelligence

The CenterWatch Monthly, April 2013

Monday, April 1, 2013 10:19 AM

20 Innovators Changing the Face of the Clinical Trials Industry

Marking CenterWatch’s 20th anniversary of its flagship publication The CenterWatch Monthly, we are publishing a special commemorative issue focusing on 20 innovators disrupting and transforming the drug development paradigm.

Although the industry is notoriously resistant to change, forward-thinking leaders realize they must explore new approaches in order to transform drug development and revitalize the industry. Many of the new approaches involve collaboration, which can be more efficient, quicker and can achieve better outcomes than R&D centered in pharmaceutical companies.

“From collaboration to crowdsourcing to consolidation, these innovations and the people behind them truly are making a difference,” said Joan Chambers, chief operating officer of CenterWatch. “At every phase of development—from early R&D to study conduct to post-approval—innovators share a common vision: to engage patients and other stakeholders as partners in the process to deliver new treatments to patients more quickly, safely and efficiently...”

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.